← back to search

I. L. Ray-Coquard

Université Claude Bernard Lyon 1 · FR
Area of research
Reproductive Medicine · Pulmonary and Respiratory Medicine
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Sarcoma Diagnosis and Treatment, PARP inhibition in cancer therapy, and Endometrial and Cervical Cancer Treatments.
h-index
16
citations
1,718
works
95
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Incorporating immune checkpoint inhibitors in epithelial ovarian cancer
Gynecologic Oncology 2025cited by 37position: middledoi
Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup
The Lancet Oncology 2024cited by 21position: middledoi
PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients
Gynecologic Oncology 2023cited by 34position: lastdoi
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
The Lancet Oncology 2022cited by 139position: middledoi
Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
European Journal of Cancer 2022cited by 21position: middledoi
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial
The Lancet Oncology 2021cited by 148position: middledoi
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
International Journal of Gynecological Cancer 2019cited by 397position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Domenica Lorusso · Pontifícia Universidade Católica de São Paulo2 papers (2023–2025)Jonathan A. Ledermann · University College London2 papers (2019–2025)— · 1 papers (2023–2023)Sandro Pignata · Iter1 papers (2019–2019)Jean‐Emmanuel Kurtz · Inserm1 papers (2025–2025)Thibault De La Motte Rouge · Centre Eugène Marquis1 papers (2023–2023)François Planchamp · Institut Bergonié1 papers (2019–2019)— · 1 papers (2023–2023)Iain A. McNeish · Ovarian Cancer Action1 papers (2019–2019)Anne Floquet · Institut Bergonié1 papers (2023–2023)Philippe Zrounba · Centre de Recherche en Cancérologie de Lyon1 papers (2022–2022)Pierre-Étienne Heudel · B. Braun (France)1 papers (2022–2022)Nicoletta Colombo · University of Milan1 papers (2019–2019)— · 1 papers (2023–2023)Kathleen Moore · University of Virginia1 papers (2025–2025)Thomas Bachelot · Institut Bergonié1 papers (2022–2022)Bertrand Favier · Université Claude Bernard Lyon 11 papers (2022–2022)Laure Favier · Hôpital Européen Georges-Pompidou1 papers (2023–2023)— · 1 papers (2023–2023)Souad Assaad · Université Claude Bernard Lyon 11 papers (2022–2022)